-
1
-
-
0029035412
-
Budesonide-β-D-glucuronide: A potential prodrug for treatment of ulcerative colitis [J]
-
Nolen HW, Fedorak RN, Friend DR. Budesonide-β-D-glucuronide: A potential prodrug for treatment of ulcerative colitis [J]. J Pharm Sci, 1995,84(6):677-681.
-
(1995)
J Pharm Sci
, vol.84
, Issue.6
, pp. 677-681
-
-
Nolen, H.W.1
Fedorak, R.N.2
Friend, D.R.3
-
2
-
-
0028017874
-
Enteric coated timed release systems for colonic targeting [J]
-
Wilding IR, Davis SS, Pozzi F, et al. Enteric coated timed release systems for colonic targeting [J]. Int J Pharm, 1994,111(1):99- 102.
-
(1994)
Int J Pharm
, vol.111
, Issue.1
, pp. 99-102
-
-
Wilding, I.R.1
Davis, S.S.2
Pozzi, F.3
-
3
-
-
0035155157
-
Colon-specific prodrugs of 5-aminosalicylic acid: Synthesis and in vitro/in vivo properties of acidic amino acid derivatives of 5-aminosalicylic acid [J]
-
Jung YJ, Lee JS, Kim YM. Colon-specific prodrugs of 5-aminosalicylic acid: synthesis and in vitro/in vivo properties of acidic amino acid derivatives of 5-aminosalicylic acid [J]. J Pharm Sci, 2001,90(11):1767-1775.
-
(2001)
J Pharm Sci
, vol.90
, Issue.11
, pp. 1767-1775
-
-
Jung, Y.J.1
Lee, J.S.2
Kim, Y.M.3
-
4
-
-
1542577514
-
Pharmacokinetics of site-specific delivery of dexamethasone-dextran prodrug in rat gastrointestinal tract [J]
-
Zhou SY, Mei QB, Zhou J, et al. Pharmacokinetics of site-specific delivery of dexamethasone-dextran prodrug in rat gastrointestinal tract [J]. Acta Pharm Sin, 2001,36(5):325-328.
-
(2001)
Acta Pharm Sin
, vol.36
, Issue.5
, pp. 325-328
-
-
Zhou, S.Y.1
Mei, Q.B.2
Zhou, J.3
-
5
-
-
0034806760
-
Colon-specific delivery of budesonide from microencapsulated cellulosic cores: Evaluation of the efficacy against colonic inflammation in rats [J]
-
Rodriguez M, Antunez JA, Taboada C, et al. Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats [J]. J Pharm Pharmacol, 2001,53(9):1207-1215.
-
(2001)
J Pharm Pharmacol
, vol.53
, Issue.9
, pp. 1207-1215
-
-
Rodriguez, M.1
Antunez, J.A.2
Taboada, C.3
-
6
-
-
0032473475
-
Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers [J]
-
Muraoka M, Hu Z, Shimokawa T, et al. Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers [J]. J Controlled Release, 1998,52(1/2):119- 129.
-
(1998)
J Controlled Release
, vol.52
, Issue.1-2
, pp. 119-129
-
-
Muraoka, M.1
Hu, Z.2
Shimokawa, T.3
-
7
-
-
0041335475
-
Study on the enzyme dependent colon targeting prodrug-dexamethasone succinate dextran and its tablets [J]
-
Pang YN, Zhang ZR, Pang QJ, et al. Study on the enzyme dependent colon targeting prodrug-dexamethasone succinate dextran and its tablets [J]. Acta Pharm Sin, 2001,36(8):625-630.
-
(2001)
Acta Pharm Sin
, vol.36
, Issue.8
, pp. 625-630
-
-
Pang, Y.N.1
Zhang, Z.R.2
Pang, Q.J.3
-
8
-
-
0004252436
-
Synthesis and delivery characteristics of colon-specific dexamethasone prodrug [J]
-
Zhou SY, Mei QB, Zhao DH. Synthesis and delivery characteristics of colon-specific dexamethasone prodrug [J]. J Med Coll PLA, 2000,15(2):91-93.
-
(2000)
J Med Coll PLA
, vol.15
, Issue.2
, pp. 91-93
-
-
Zhou, S.Y.1
Mei, Q.B.2
Zhao, D.H.3
-
9
-
-
0027231706
-
Synthesis and chemical stability of glucocorticoid-dextran esters: Potential prodrugs for colon-specific delivery [J]
-
McLeod AD, Friend DR, Tozer TN. Synthesis and chemical stability of glucocorticoid-dextran esters: potential prodrugs for colon-specific delivery [J]. Int J Pharm, 1993,92(2):105-114.
-
(1993)
Int J Pharm
, vol.92
, Issue.2
, pp. 105-114
-
-
McLeod, A.D.1
Friend, D.R.2
Tozer, T.N.3
-
10
-
-
0036068518
-
Colon-specific delivery release mechanism of prednisolone-dextran prodrug [J]
-
Zhou J, Mei QB, LI P, et al. Colon-specific delivery release mechanism of prednisolone-dextran prodrug [J]. Chin Pharmacol Bull, 2002,18(3):328-330.
-
(2002)
Chin Pharmacol Bull
, vol.18
, Issue.3
, pp. 328-330
-
-
Zhou, J.1
Mei, Q.B.2
LI, P.3
|